000 01629 a2200493 4500
005 20250513231935.0
264 0 _c20010315
008 200103s 0 0 eng d
022 _a0012-186X
024 7 _a10.1007/s001250051587
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aForbes, J M
245 0 0 _aRenoprotective effects of a novel inhibitor of advanced glycation.
_h[electronic resource]
260 _bDiabetologia
_cJan 2001
300 _a108-14 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCross-Linking Reagents
650 0 4 _aDiabetes Mellitus, Experimental
_xcomplications
650 0 4 _aDiabetic Nephropathies
_xprevention & control
650 0 4 _aEnzyme Inhibitors
650 0 4 _aGlomerular Filtration Rate
650 0 4 _aGlycation End Products, Advanced
_xanalysis
650 0 4 _aGuanidines
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aKidney
_xchemistry
650 0 4 _aKidney Glomerulus
_xchemistry
650 0 4 _aMale
650 0 4 _aNitric Oxide Synthase
_xantagonists & inhibitors
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aSerum Albumin, Bovine
700 1 _aSoulis, T
700 1 _aThallas, V
700 1 _aPanagiotopoulos, S
700 1 _aLong, D M
700 1 _aVasan, S
700 1 _aWagle, D
700 1 _aJerums, G
700 1 _aCooper, M E
773 0 _tDiabetologia
_gvol. 44
_gno. 1
_gp. 108-14
856 4 0 _uhttps://doi.org/10.1007/s001250051587
_zAvailable from publisher's website
999 _c11144418
_d11144418